Aurinia Pharmaceuticals Inc (AUPH)

Last Closing Price: 14.37 (2026-03-09)

Net Income (Annual)

Net Income: Company's net profit or loss after all revenues, income items, and expenses have been accounted for. Because this figure is given after preferred dividend expense, it is the net income value allotted to common shareholders.

Aurinia Pharmaceuticals Inc (AUPH) had Net Income of $287.20M for the most recently reported fiscal year, ending 2025-12-31.

Figures for fiscal year ending 2025-12-31
Income Statement Financials
$283.06M
Net Income
$287.20M
$32.66M
$250.39M
$168.61M
$114.44M
$-0.29M
$114.16M
$114.16M
$287.20M
$287.20M
$287.20M
$287.20M
$114.44M
$133.89M
134.37M
138.70M
$2.14
$2.07
Balance Sheet Financials
$491.97M
$2.11M
$259.62M
$751.59M
$93.72M
$52.32M
$76.53M
$170.26M
$581.33M
$577.57M
$581.33M
132.32M
Cash Flow Statement Financials
$135.66M
$-32.77M
$-106.11M
$83.43M
$80.21M
$-3.22M
$14.68M
--
--
Fundamental Metrics & Ratios
5.25
--
--
0.08
0.12
88.46%
40.43%
40.43%
47.30%
40.33%
101.47%
$135.41M
--
--
--
0.38
0.71
6.83
53.45
49.40%
49.73%
38.21%
45.32%
$4.39
$0.98
$0.98